Transcription elongation past O6-methylguanine by human RNA polymerase II and bacteriophage T7 RNA polymerase

Alexandra Dimitri, John A. Burns, Suse Broyde, David A. Scicchitano

Research output: Contribution to journalArticle

Abstract

O6-Methylguanine (O6-meG) is a major mutagenic, carcinogenic and cytotoxic DNA adduct produced by various endogenous and exogenous methylating agents. We report the results of transcription past a site-specifically modified O6-meG DNA template by bacteriophage T7 RNA polymerase and human RNA polymerase II. These data show that O6-meG partially blocks T7 RNA polymerase and human RNA polymerase II elongation. In both cases, the sequences of the truncated transcripts indicate that both polymerases stop precisely at the damaged site without nucleotide incorporation opposite the lesion, while extensive misincorporation of uracil is observed in the full-length RNA. For both polymerases, computer models suggest that bypass occurs only when O6-meG adopts an anti conformation around its glycosidic bond, with the methyl group in the proximal orientation; in contrast, blockage requires the methyl group to adopt a distal conformation. Furthermore, the selection of cytosine and uracil partners opposite O6-meG is rationalized with modeled hydrogen-bonding patterns that agree with experimentally observed O6-meG:C and O6-meG:U pairing schemes. Thus, in vitro, O6-meG contributes substantially to transcriptional mutagenesis. In addition, the partial blockage of RNA polymerase II suggests that transcription-coupled DNA repair could play an auxiliary role in the clearance of this lesion.

Original languageEnglish (US)
Pages (from-to)6459-6471
Number of pages13
JournalNucleic Acids Research
Volume36
Issue number20
DOIs
StatePublished - 2008

Fingerprint

RNA Phages
RNA Polymerase II
Uracil
DNA Adducts
O-(6)-methylguanine
bacteriophage T7 RNA polymerase
Cytosine
Hydrogen Bonding
Mutagenesis
DNA Repair
Computer Simulation
Nucleotides
RNA

ASJC Scopus subject areas

  • Genetics

Cite this

Transcription elongation past O6-methylguanine by human RNA polymerase II and bacteriophage T7 RNA polymerase. / Dimitri, Alexandra; Burns, John A.; Broyde, Suse; Scicchitano, David A.

In: Nucleic Acids Research, Vol. 36, No. 20, 2008, p. 6459-6471.

Research output: Contribution to journalArticle

@article{9082c0f5667f4c3db318c6f918dc2032,
title = "Transcription elongation past O6-methylguanine by human RNA polymerase II and bacteriophage T7 RNA polymerase",
abstract = "O6-Methylguanine (O6-meG) is a major mutagenic, carcinogenic and cytotoxic DNA adduct produced by various endogenous and exogenous methylating agents. We report the results of transcription past a site-specifically modified O6-meG DNA template by bacteriophage T7 RNA polymerase and human RNA polymerase II. These data show that O6-meG partially blocks T7 RNA polymerase and human RNA polymerase II elongation. In both cases, the sequences of the truncated transcripts indicate that both polymerases stop precisely at the damaged site without nucleotide incorporation opposite the lesion, while extensive misincorporation of uracil is observed in the full-length RNA. For both polymerases, computer models suggest that bypass occurs only when O6-meG adopts an anti conformation around its glycosidic bond, with the methyl group in the proximal orientation; in contrast, blockage requires the methyl group to adopt a distal conformation. Furthermore, the selection of cytosine and uracil partners opposite O6-meG is rationalized with modeled hydrogen-bonding patterns that agree with experimentally observed O6-meG:C and O6-meG:U pairing schemes. Thus, in vitro, O6-meG contributes substantially to transcriptional mutagenesis. In addition, the partial blockage of RNA polymerase II suggests that transcription-coupled DNA repair could play an auxiliary role in the clearance of this lesion.",
author = "Alexandra Dimitri and Burns, {John A.} and Suse Broyde and Scicchitano, {David A.}",
year = "2008",
doi = "10.1093/nar/gkn657",
language = "English (US)",
volume = "36",
pages = "6459--6471",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "20",

}

TY - JOUR

T1 - Transcription elongation past O6-methylguanine by human RNA polymerase II and bacteriophage T7 RNA polymerase

AU - Dimitri, Alexandra

AU - Burns, John A.

AU - Broyde, Suse

AU - Scicchitano, David A.

PY - 2008

Y1 - 2008

N2 - O6-Methylguanine (O6-meG) is a major mutagenic, carcinogenic and cytotoxic DNA adduct produced by various endogenous and exogenous methylating agents. We report the results of transcription past a site-specifically modified O6-meG DNA template by bacteriophage T7 RNA polymerase and human RNA polymerase II. These data show that O6-meG partially blocks T7 RNA polymerase and human RNA polymerase II elongation. In both cases, the sequences of the truncated transcripts indicate that both polymerases stop precisely at the damaged site without nucleotide incorporation opposite the lesion, while extensive misincorporation of uracil is observed in the full-length RNA. For both polymerases, computer models suggest that bypass occurs only when O6-meG adopts an anti conformation around its glycosidic bond, with the methyl group in the proximal orientation; in contrast, blockage requires the methyl group to adopt a distal conformation. Furthermore, the selection of cytosine and uracil partners opposite O6-meG is rationalized with modeled hydrogen-bonding patterns that agree with experimentally observed O6-meG:C and O6-meG:U pairing schemes. Thus, in vitro, O6-meG contributes substantially to transcriptional mutagenesis. In addition, the partial blockage of RNA polymerase II suggests that transcription-coupled DNA repair could play an auxiliary role in the clearance of this lesion.

AB - O6-Methylguanine (O6-meG) is a major mutagenic, carcinogenic and cytotoxic DNA adduct produced by various endogenous and exogenous methylating agents. We report the results of transcription past a site-specifically modified O6-meG DNA template by bacteriophage T7 RNA polymerase and human RNA polymerase II. These data show that O6-meG partially blocks T7 RNA polymerase and human RNA polymerase II elongation. In both cases, the sequences of the truncated transcripts indicate that both polymerases stop precisely at the damaged site without nucleotide incorporation opposite the lesion, while extensive misincorporation of uracil is observed in the full-length RNA. For both polymerases, computer models suggest that bypass occurs only when O6-meG adopts an anti conformation around its glycosidic bond, with the methyl group in the proximal orientation; in contrast, blockage requires the methyl group to adopt a distal conformation. Furthermore, the selection of cytosine and uracil partners opposite O6-meG is rationalized with modeled hydrogen-bonding patterns that agree with experimentally observed O6-meG:C and O6-meG:U pairing schemes. Thus, in vitro, O6-meG contributes substantially to transcriptional mutagenesis. In addition, the partial blockage of RNA polymerase II suggests that transcription-coupled DNA repair could play an auxiliary role in the clearance of this lesion.

UR - http://www.scopus.com/inward/record.url?scp=56649113063&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56649113063&partnerID=8YFLogxK

U2 - 10.1093/nar/gkn657

DO - 10.1093/nar/gkn657

M3 - Article

VL - 36

SP - 6459

EP - 6471

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 20

ER -